source
- FDA issues new guidance for pharma on discussing unapproved drugs with payorsThe FDA has released guidance aimed at biopharma companies that are preparing to launch new therapies before they receive formal approval. The advice focuses on how companies can inform health-pla…
- Bristol Myers Squibb assesses AI spending after deploying tools to thousands of staffBristol Myers Squibb has recently provided artificial intelligence applications to a large portion of its workforce. The company is now turning its attention to measuring the cost of these tools a…